Introduction
According to World Health Organization’s (WHO) report of pharmaceuticals consumption, medicines for the treatment of chronic diseases accumulated the larger amount of the total volume of drug utilization in non hospital set ups, resulting in the considerable rise in the number of available medicines to the consumers. Pharmacovigilance outsourcing includes risk management, signal management, data management, and inspection support. The report provides analysis of global pharmacovigilance outsourcing market for the period 2016-2026, wherein 2018 to 2026 is the forecast period and 2017 is considered as the base year. The global pharmacovigilance outsourcing market is anticipated to grow at substantial CAGR above 16% throughout the forecast period. Furthermore, Market players are primarily focusing on developing new innovative technologies that will supplement growth of the pharmacovigilance outsourcing market.
Market Dynamics
Growing prominence on new drug development for chronic diseases treatments, remote monitoring for clinical operations, quality assurance, regulatory affairs, statistical analysis and clinical trials, increasing preference of pharma companies towards PV outsourcing facilities and rising number of unfavourable events and other safety concerns related to the medical products are some of the fundamental factors that are driving the global pharmacovigilance outsourcing market growth globally. Growing safety concerns related to the medical products and rising number of adverse measures are the major factors boosting the global pharmacovigilance (PV) outsourcing market growth. Benefits provided by outsourcing facilities for in-house agreement functions is forecasted to drive the global pharmacovigilance outsourcing market over the forecast period. Increasing adoption of pharmacovigilance IT solutions and services are projected to spur the growth of the market over the forecast period. Additionally, due to the numerous advancements in drug development process is boosting the growth of the market. Large numbers of pharma companies are primarily focusing on the outsourcing PV services in order to minimize the operational expenses and reduce the overall cost, thereby fueling the growth of the market. Nevertheless, risks associated with security of data such as mistreatment of patient’s data may hamper the growth of the global pharmacovigilance outsourcing market.
Market Segmentation
Pharmacovigilance Outsourcing Market, By Service
- Pre-marketing services
- Clinical pharmacovigilance services
- Case processing services
- Safety data management services
- Medical review
- Post-marketing services
- Knowledge process outsourcing services
- IT solutions and services
- Others
Pharmacovigilance Outsourcing Market, By Service Provider
- Contract research organizations (CROs)
- Business process outsourcing (BPOs)
Global Pharmacovigilance outsourcing Market, by Geography
- Europe
- UK
- Germany
- France
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Chile
- Rest of Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- Rest of MEA
The market research study on “Pharmacovigilance Outsourcing Market (By Service: Pre-marketing services [Clinical pharmacovigilance services, Case processing services, Safety data management services, Medical review], Post-marketing services [Knowledge process outsourcing services, IT solutions and services], Others; By Service Provider: Contract research organizations (CROs), Business process outsourcing (BPOs)) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers a detailed insights on global pharmacovigilance outsourcing market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global pharmacovigilance outsourcing market by service, service providers, fuel, distribution channel and major geographic regions. The report also covers basic drug development policies.
Market Participants
The global pharmacovigilance outsourcing market is characterized by the presence of experienced and established players. Some of the key players include Bioclinica, Clintec, Covance, Medpace Holdings, Oracle Corporation, iGATE Corporation, Accenture, iMED Global Corporation, Symogen, Ergomed, IBM Corporation, IQVIA, MarksMan Healthcare, Parexel, SIRO Clinpharm and Novartis. Various prominent players from the market are entering into strategic acquisitions in order to offer advanced pharmacovigilance outsourcing technologies to their clients. Additionally, they are focusing on strategic acquisitions in order to expand their industry presence.
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Pharmacovigilance Outsourcing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Pharmacovigilance Outsourcing Market By Service
1.2.2.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison By Service (2015-2026)
1.2.2.2. Global Pharmacovigilance Outsourcing Market Revenue Share By Service in 2017
1.2.2.3. Pre-marketing services
1.2.2.4. Post-marketing services
1.2.2.5. Others
1.2.3. Pharmacovigilance Outsourcing Market By Service Provider
1.2.3.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison By Service Provider (2015-2026)
1.2.3.2. Global Pharmacovigilance Outsourcing Market Revenue Share By Service Provider in 2017
1.2.3.3. Contract research organizations (CROs)
1.2.3.4. Business process outsourcing (BPOs)
1.2.3.5. Others
1.2.4. Pharmacovigilance Outsourcing Market by Geography
1.2.4.1. Global Pharmacovigilance Outsourcing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Pharmacovigilance Outsourcing Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Pharmacovigilance Outsourcing Major Manufacturers in 2017
CHAPTER 4. PHARMACOVIGILANCE OUTSOURCING MARKET BY SERVICE
4.1. Global Pharmacovigilance Outsourcing Revenue By Service
4.2. Pre-marketing services
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Post-marketing services
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. PHARMACOVIGILANCE OUTSOURCING MARKET BY SERVICE PROVIDER
5.1. Global Pharmacovigilance Outsourcing Revenue By Service Provider
5.2. Contract research organizations (CROs)
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Business process outsourcing (BPOs)
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. NORTH AMERICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY
6.1. North America Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Pharmacovigilance Outsourcing Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
CHAPTER 7. EUROPE PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY
7.1. Europe Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
CHAPTER 8. ASIA-PACIFIC PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY
8.1. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
CHAPTER 9. LATIN AMERICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY
9.1. Latin America Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
CHAPTER 10. MIDDLE EAST PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY
10.1. Middle East Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
CHAPTER 11. AFRICA PHARMACOVIGILANCE OUTSOURCING MARKET BY COUNTRY
11.1. Africa Pharmacovigilance Outsourcing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Pharmacovigilance Outsourcing Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Service, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Service Provider, 2015 - 2026 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. Bioclinica
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Clintec
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Covance
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Medpace Holdings
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Oracle Corporation
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. iGATE Corporation
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Accenture
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. iMED Global Corporation
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Symogen
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Ergomed
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. IBM Corporation
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. IQVIA
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies
12.13. MarksMan Healthcare
12.13.1. Company Snapshot
12.13.2. Overview
12.13.3. Financial Overview
12.13.4. Product Portfolio
12.13.5. Key Developments
12.13.6. Strategies
12.14. Parexel
12.14.1. Company Snapshot
12.14.2. Overview
12.14.3. Financial Overview
12.14.4. Product Portfolio
12.14.5. Key Developments
12.14.6. Strategies
12.15. SIRO Clinpharm
12.15.1. Company Snapshot
12.15.2. Overview
12.15.3. Financial Overview
12.15.4. Product Portfolio
12.15.5. Key Developments
12.15.6. Strategies
12.16. Novartis
12.16.1. Company Snapshot
12.16.2. Overview
12.16.3. Financial Overview
12.16.4. Product Portfolio
12.16.5. Key Developments
12.16.6. Strategies
12.17. Others
12.17.1. Company Snapshot
12.17.2. Overview
12.17.3. Financial Overview
12.17.4. Product Portfolio
12.17.5. Key Developments
12.17.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
![Pharmacovigilance Outsourcing Market (By Service: Pre-marketing services [Clinical pharmacovigilance services, Case processing services, Safety data management services, Medical review], Post-marketing services [Knowledge process outsourcing services, IT solutions and services], Others; By Service Provider: Contract research organizations (CROs), Business process outsourcing (BPOs)) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026](assets/images/format-png.png "Pharmacovigilance Outsourcing Market (By Service: Pre-marketing services [Clinical pharmacovigilance services, Case processing services, Safety data management services, Medical review], Post-marketing services [Knowledge process outsourcing services, IT solutions and services], Others; By Service Provider: Contract research organizations (CROs), Business process outsourcing (BPOs)) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026")
